Steven J. Sell's most recent trade in Agilon Health Inc was a trade of 22,563 Common Stock done at an average price of $5.5 . Disclosure was reported to the exchange on April 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Agilon Health Inc | Steven J. Sell | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.53 per share. | 14 Apr 2025 | 22,563 | 862,122 | - | 5.5 | 124,773 | Common Stock |
| Agilon Health Inc | Steven J. Sell | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.60 per share. | 14 Apr 2025 | 7,898 | 884,685 | - | 5.6 | 44,229 | Common Stock |
| Agilon Health Inc | Steven J. Sell | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 865,385 | 865,385 | - | - | Options (Right to buy) | |
| Agilon Health Inc | Steven J. Sell | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 551,471 | 906,781 | - | 0 | Common Stock | |
| Agilon Health Inc | Steven J. Sell | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 14 Mar 2025 | 42,426 | 370,873 | - | - | Common Stock | |
| Agilon Health Inc | Steven J. Sell | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.05 per share. | 14 Mar 2025 | 15,563 | 355,310 | - | 4.0 | 63,030 | Common Stock |
| Agilon Health Inc | Steven J. Sell | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 3.36 per share. | 12 Sep 2024 | 20,000 | 67,590 | - | 3.4 | 67,188 | Common Stock |
| Agilon Health Inc | Steven J. Sell | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2024 | 415,130 | 415,130 | - | - | Options (Right to buy) | |
| Agilon Health Inc | Steven J. Sell | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2024 | 252,243 | 336,322 | - | 0 | Common Stock | |
| Agilon Health Inc | Steven J. Sell | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.95 per share. | 14 Apr 2024 | 7,875 | 328,447 | - | 4.9 | 38,981 | Common Stock |
| Agilon Health Inc | Steven J. Sell | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 11.14 per share. | 21 Nov 2023 | 44,690 | 47,590 | - | 11.1 | 497,739 | Common Stock |
| Agilon Health Inc | Steven J. Sell | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 68,348 | 68,348 | - | - | Options (Right to buy) | |
| Agilon Health Inc | Steven J. Sell | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 39,530 | 88,295 | - | 0 | Common Stock | |
| Agilon Health Inc | Steven J. Sell | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.46 per share. | 14 Apr 2023 | 4,216 | 84,079 | - | 28.5 | 119,987 | Common Stock |
| Agilon Health Inc | Steven J. Sell | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 17.14 per share. | 18 Nov 2022 | 2,900 | 2,900 | - | 17.1 | 49,705 | Common Stock |
| Agilon Health Inc | Steven J. Sell | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2022 | 160,486 | 160,486 | - | - | Options (Rights to Buy) | |
| Agilon Health Inc | Steven J. Sell | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2022 | 48,765 | 48,765 | - | 0 | Common Stock | |
| Agilon Health Inc | Steven J. Sell | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.50 per share. | 14 Sep 2021 | 100,000 | 100,000 | - | 4.5 | 450,000 | Common Stock |
| Agilon Health Inc | Steven J. Sell | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 28.98 per share. | 14 Sep 2021 | 100,000 | 0 | - | 29.0 | 2,898,000 | Common Stock |
| Agilon Health Inc | Steven J. Sell | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2021 | 100,000 | 900,000 | - | - | Options (Rights to Buy) |